Coupled Chemo(enzymatic) Reactions in Continuous Flow
News Jul 17, 2012
For a long time, the living cell has been considered to be a perfect chemical factory, whose organizational principles can inspire every organic chemist and chemical engineer. The effectiveness, with which nutrients are converted into complex chemical building blocks required for the cell metabolism, is still a distant goal for any man-made chemical factory. Metabolic pathways, consisting of enzymatic sequential and coupled reactions, lie at the core of any living system and have been optimized by evolution over billions of years to create the phenomenon of life as we know it. In the field of applied biocatalysis, chemists are constantly trying to recognize the principles responsible for the efficiency of cell metabolism and to exploit them in organic synthesis. There are three biological principles whose implementation may be regarded as important milestones in this field and which can be used for the classification of existing biotransformations. One of these principles is that a single reaction step of a given metabolic pathway proceeds in a very specific manner due to the intrinsically high chemo-, regio- and stereoselectivity of the enzyme catalyzing this step. This principle is the soul of applied biocatalysis and has already been widely exploited in the chemical industry for decades in the production of chemicals by enzymatic processes. Biotransformations solely based on this principle, i.e., “single-reaction–singleenzyme” systems, may be classified as first-generation enzymatic processes, which historically were the first to be applied in the chemical industry and till now remain the most abundant among industrial biotransformations.
The article is published online in Beilstein Journal of Organic Chemistry and is free to access.
Novel Artificial Photosynthesis Device for Greener Ethylene ProductionNews
A team of scientists from the National University of Singapore (NUS) has developed a prototype device that mimics natural photosynthesis to produce ethylene gas using only sunlight, water and carbon dioxide.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE